NCT00342875View on ClinicalTrials.gov

The New England Bladder Cancer Study

CompletedOBSERVATIONAL

Enrollment

2,681

Participants

Timeline

Start Date

March 1, 2002

Primary Completion Date

June 16, 2004

Study Completion Date

July 14, 2020

Conditions

Bladder Cancer

Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00342875 - The New England Bladder Cancer Study | Biotech Hunter | Biotech Hunter